{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:44:03Z","timestamp":1793295843651,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2003,5,14]],"date-time":"2003-05-14T00:00:00Z","timestamp":1052870400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1038\/sj.npp.1300232","type":"journal-article","created":{"date-parts":[[2003,6,25]],"date-time":"2003-06-25T05:23:30Z","timestamp":1056518610000},"page":"1694-1702","source":"Crossref","is-referenced-by-count":296,"title":["Association Between A2a Receptor Gene Polymorphisms and Caffeine-Induced Anxiety"],"prefix":"10.1038","volume":"28","author":[{"given":"Karen","family":"Alsene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Deckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Sand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,5,14]]},"reference":[{"key":"BF1300232_CR1","unstructured":"American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th Edition Text Revised. American Psychiatric Association: Washington, DC."},{"key":"BF1300232_CR2","unstructured":"Belkhir K, Borsa P, Chiki L, Raufaste N, Bonhomme F (2001). 1996\u20132001 GENETIX 4.02, logiciel sous Windows TM pour la genetique des populations. Laboratoire Genome, Populations, Interactions, CNRS UMR 5000. Universite de Montpellier II: Montpellier."},{"key":"BF1300232_CR3","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1001\/archpsyc.1983.01790220057009","volume":"41","author":"JP Boulenger","year":"1984","unstructured":"Boulenger JP, Uhde TW, Wolff EA, Post RM (1984). Increased sensitivity to caffeine in patients with panic disorders. Arch Gen Psychiatry 41: 1067\u20131071.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300232_CR4","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1093\/nar\/19.13.3549","volume":"19","author":"I Brukner","year":"1991","unstructured":"Brukner I, Jurukovski V, Konstantinovic M, Savic A (1991). Curved DNA without AA\/TT dinucleotide step. Nucleic Acids Res 19: 3549\u20133551.","journal-title":"Nucleic Acids Res"},{"key":"BF1300232_CR5","first-page":"219","volume":"3","author":"LD Chait","year":"1992","unstructured":"Chait LD (1992). Factors influencing the subjective response to caffeine. Behav. Pharmacol 3: 219\u2013228.","journal-title":"Behav. Pharmacol"},{"key":"BF1300232_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1001\/archpsyc.1985.01790260027003","volume":"42","author":"DS Charney","year":"1985","unstructured":"Charney DS, Heninger GR, Jallon PI (1985). Increased anxiogenic effects of caffeine in panic disorder. Arch Gen Psychiatry 42: 233\u2013243.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300232_CR7","first-page":"570","volume":"105","author":"J Deckert","year":"2001","unstructured":"Deckert J, Kuhlenb\u00e4umer G, Wei\u00df K, Schirmacher A, Ringelstein EB, Arolt V et al (2001). Chromosome 22q11.2 as a candidate gene locus: association of the more active COMT-allele with panic disorder. Am J Med Genet 105: 570.","journal-title":"Am J Med Genet"},{"key":"BF1300232_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/(SICI)1096-8628(19980207)81:1<18::AID-AJMG4>3.0.CO;2-J","volume":"81","author":"J Deckert","year":"1998","unstructured":"Deckert J, Nothen MM, Albus M, Franzek E, Rietschel M, Ren H et al (1998a). Adenosine A1 receptor and bipolar affective disorder: systematic screening of the gene and association studies. Am J Med Genet 81: 18\u201323.","journal-title":"Am J Med Genet"},{"key":"BF1300232_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/sj.mp.4000345","volume":"3","author":"J Deckert","year":"1998","unstructured":"Deckert J, Nothen MM, Franke P, Delmo C, Fritze J, Knapp M et al (1998b). Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 3: 81\u201385.","journal-title":"Mol Psychiatry"},{"key":"BF1300232_CR10","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/BF01271259","volume":"103","author":"J Deckert","year":"1996","unstructured":"Deckert J, Nothen MM, Rietschel M, Wildenauer D, Bondy B, Ertl MA et al (1996). Human adenosine A2a receptor (A2aAR) gene: systematic mutation screening in patients with schizophrenia. J Neural Transm 103: 1447\u20131455.","journal-title":"J Neural Transm"},{"key":"BF1300232_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N","volume":"15","author":"JT den Dunnen","year":"2000","unstructured":"den Dunnen JT, Antonorakis SE (2000). Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 15: 7\u201312.","journal-title":"Hum Mutat."},{"key":"BF1300232_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1331\/108658002763029607","volume":"42","author":"KL Durrant","year":"2002","unstructured":"Durrant KL (2002). Known and hidden sources of caffeine in drug, food, and natural products. J Am Pharm Assoc (Wash.) 42: 625\u2013637.","journal-title":"J Am Pharm Assoc (Wash.)"},{"key":"BF1300232_CR13","first-page":"345","volume":"2","author":"SM Evans","year":"1991","unstructured":"Evans SM, Griffiths RR (1991). Dose-related caffeine discrimination in normal volunteers: individual differences in subjective and self-reported cues. Behav Pharmacol 2: 345\u2013356.","journal-title":"Behav Pharmacol"},{"key":"BF1300232_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1037\/10500-009","volume-title":"The Impulsive Client","author":"SBG Eysenck","year":"1993","unstructured":"Eysenck SBG (1993). The I7: development of a measure of impulsivity and its relationship to personality. In: McCown WG, Johnson JL, Shure MB (eds) The Impulsive Client. American Psychological Association: Washington, DC. pp 141\u2013149."},{"key":"BF1300232_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s002100000313","volume":"362","author":"BB Fredholm","year":"2000","unstructured":"Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W (2000). Structure and function of adenosine receptors and their genes. Arch Pharmacol 362: 364\u2013377.","journal-title":"Arch Pharmacol"},{"key":"BF1300232_CR16","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1038\/sj.onc.1203064","volume":"18","author":"L Fu","year":"1999","unstructured":"Fu L, Ma WL, Benchimol S (1999). A translation repressor element resides in the 3\u2032 untranslated region of human p53 mRNA. Oncogene 18: 6419\u20136424.","journal-title":"Oncogene"},{"key":"BF1300232_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0014-5793(96)00855-1","volume":"393","author":"A Gabrielian","year":"1996","unstructured":"Gabrielian A, Pongor S (1996). Correlation of intrinsic DNA curvature with DNA property periodicity. FEBS Lett 393: 65\u201368.","journal-title":"FEBS Lett"},{"key":"BF1300232_CR18","first-page":"49","volume-title":"Research Advances in Alcohol and Drug Problems","author":"RM Gilbert","year":"1976","unstructured":"Gilbert RM (1976). Caffeine as a drug of abuse. In: Gibbins RJ, Israel Y, Kalant H, Popham RE, Schmidt W, Smart RG (eds) Research Advances in Alcohol and Drug Problems, Vol. 3 Wiley: New York. pp 49\u2013176."},{"key":"BF1300232_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/cpt1969104489","volume":"10","author":"A Goldstein","year":"1969","unstructured":"Goldstein A, Kaizer S, Whitby O (1969). Psychotropic effects of caffeine in man. IV. Quantitative and Qualitative differences associated with habituation to coffee. Clin Pharmacol Therap 10: 489\u2013497.","journal-title":"Clin Pharmacol Therap"},{"key":"BF1300232_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1753-4887.1978.tb03717.x","volume":"36","author":"DM Graham","year":"1978","unstructured":"Graham DM (1978). Caffeine\u2014its identity, dietary sources, intake and biological effects. Nutr Rev 36: 97\u2013102.","journal-title":"Nutr Rev"},{"key":"BF1300232_CR21","volume-title":"Pharmacological Aspects of Drug Dependence","author":"RR Griffiths","year":"1996","unstructured":"Griffiths RR, Mumford GK (1996). Caffeine reinforcement, discrimination, tolerance and physical dependence in laboratory animals and humans. In: Schuster CR, Kuhar MJ (eds). Pharmacological Aspects of Drug Dependence, (Chapter 9) Springer Verlag: Berlin."},{"key":"BF1300232_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0091-3057(88)90180-3","volume":"29","author":"RR Griffiths","year":"1988","unstructured":"Griffiths RR, Woodson PP (1988). Reinforcing properties of caffeine: studies in human and laboratory animals. Pharmacol Biochem Behav 29: 419\u2013427.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300232_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0091-3057(93)90480-H","volume":"44","author":"U Gupta","year":"1993","unstructured":"Gupta U (1993). Effects of caffeine on recognition. Pharmacol Biochem Behav 44: 393\u2013396.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300232_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000119159","volume":"30","author":"U Gupta","year":"1994","unstructured":"Gupta U, Dubey GP, Gupta BS (1994). Effects of caffeine on perceptual judgement. Neuropsychobiology 30: 185\u2013188.","journal-title":"Neuropsychobiology"},{"key":"BF1300232_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/bmj.2.6028.147","volume":"2","author":"P Hart","year":"1976","unstructured":"Hart P, Farrell GC, Cooksley WGE, Powell L (1976). Enhanced drug metabolism in cigarette smokers. Br Med J 2: 147\u2013149.","journal-title":"Br Med J"},{"key":"BF1300232_CR26","doi-asserted-by":"publisher","first-page":"9407","DOI":"10.1073\/pnas.161292398","volume":"98","author":"B Johansson","year":"2001","unstructured":"Johansson B, Halldner L, Dunwiddie TV, Masino SA, Poelchen W, Gimenez-Llort L et al (2001). Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci USA 98: 9407\u20139412.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1300232_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s002280050654","volume":"55","author":"GH Kamimori","year":"1999","unstructured":"Kamimori GH, Joubert A, Otterstetter R, Santaromana M, Eddington ND (1999). The effects of the menstrual cycle on the pharmacokinetics of caffeine in normal, healthy eumenorrheic females. Eur J Clin Pharmacol 55: 445\u2013449.","journal-title":"Eur J Clin Pharmacol"},{"key":"BF1300232_CR28","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/j.1552-4604.1997.tb04356.x","volume":"37","author":"GB Kaplan","year":"1997","unstructured":"Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau NM, Harmatz JS et al (1997). Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol 37: 693\u2013703.","journal-title":"J Clin Pharmacol"},{"key":"BF1300232_CR29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/ajp.156.2.223","volume":"156","author":"KS Kendler","year":"1999","unstructured":"Kendler KS, Prescott CA (1999). Caffeine intake, tolerance, and withdrawal in women: A population-based twin study. Am J Psychiatry 156: 223\u2013228.","journal-title":"Am J Psychiatry"},{"key":"BF1300232_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF00403681","volume":"14","author":"M Lader","year":"1969","unstructured":"Lader M (1969). Comparison of amphetamine sulphate and caffeine citrate in man. Psychopharmacologia 14: 83\u201394.","journal-title":"Psychopharmacologia"},{"key":"BF1300232_CR31","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/41771","volume":"388","author":"C Ledent","year":"1997","unstructured":"Ledent C, Vaugeois JM, Schiffmann SN Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ et al (1997). Aggressiveness, hypoalgesia, and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388: 674\u2013682.","journal-title":"Nature"},{"key":"BF1300232_CR32","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1176\/ajp.145.5.632","volume":"145","author":"MA Lee","year":"1988","unstructured":"Lee MA, Flegel P, Greden JF, Cameron OG (1988). Anxiogenic effects of caffeine on panic and depressed patients. Am J Psychiatry 145: 632\u2013635.","journal-title":"Am J Psychiatry"},{"key":"BF1300232_CR33","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/BF00210835","volume":"92","author":"HR Lieberman","year":"1987","unstructured":"Lieberman HR, Wurtman RJ, Emde GG, Roberts C, Coviella ILG (1987). The effects of low doses of caffeine on human performance and mood. Psychopharmacology 92: 308\u2013312.","journal-title":"Psychopharmacology"},{"key":"BF1300232_CR34","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1037\/1064-1297.7.3.244","volume":"7","author":"A Liguori","year":"1999","unstructured":"Liguori A, Grass JA, Hughes JR (1999). Subjective effects of caffeine among introverts and extraverts in the morning and evening. Exp Clin Psychopharmacol 7: 244\u2013249.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BF1300232_CR35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0031-9384(88)90039-X","volume":"44","author":"WH Loke","year":"1988","unstructured":"Loke WH (1988). Effects of caffeine on mood and memory. Physiol Behav 44: 367\u2013372.","journal-title":"Physiol Behav"},{"key":"BF1300232_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/cpt1971122part1245","volume":"12","author":"WR Martin","year":"1971","unstructured":"Martin WR, Sloan JW, Sapira JD, Jasinski RM (1971). Physiological, subjective and behavioral tests of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clin Pharmacol Ther 12: 245\u2013258.","journal-title":"Clin Pharmacol Ther"},{"key":"BF1300232_CR37","volume-title":"Profile of Mood States","author":"D McNair","year":"1971","unstructured":"McNair D, Lorr M, Droppleman DL (1971). Profile of Mood States. Educational and Industrial Testing Service: San Diego."},{"key":"BF1300232_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02244744","volume":"115","author":"GK Mumford","year":"1994","unstructured":"Mumford GK, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K et al (1994). Discriminative stimulus and subjective effects of theobromine and caffeine in humans. Psychopharmacology 115: 1\u20138.","journal-title":"Psychopharmacology"},{"key":"BF1300232_CR39","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","volume":"51","author":"JH Patton","year":"1995","unstructured":"Patton JH, Stanford MS, Barratt ES (1995). Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol 51: 768\u2013774.","journal-title":"J Clin Psychol"},{"key":"BF1300232_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/prot.340090304","volume":"9","author":"GD Schuler","year":"1991","unstructured":"Schuler GD, Altschul SF, Lipman DJ (1991). A workbench for multiple alignment construction and analysis. Proteins 9: 180\u2013190.","journal-title":"Proteins"},{"key":"BF1300232_CR41","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2466\/pms.2002.94.2.521","volume":"94","author":"WH Scott Jr","year":"2002","unstructured":"Scott Jr WH, Coyne KM, Johnson MM, Lausted CG, Sahota M, Johnson AT (2002). Effects of caffeine on performance of low intensity tasks. Percept Motor Skills 94: 521\u2013532.","journal-title":"Percept Motor Skills"},{"key":"BF1300232_CR42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1207\/s15327752jpa4703_14","volume":"47","author":"S Shacham","year":"1983","unstructured":"Shacham S (1983). A shortened version of the profile of mood states. J Pers Assess 47: 305\u2013307.","journal-title":"J Pers Assess"},{"key":"BF1300232_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0022-3956(84)90001-3","volume":"18","author":"SH Snyder","year":"1984","unstructured":"Snyder SH, Sklar P (1984). Behavioral and molecular actions of caffeine: Focus on adenosine. J Psychiatry Res 18: 91\u2013106.","journal-title":"J Psychiatry Res"},{"key":"BF1300232_CR44","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1089\/10445490152122451","volume":"20","author":"X Song","year":"2001","unstructured":"Song X, Singh SM (2001). Distribution and molecular characterization of mRNA-bending proteins specific to the (U)15 region of 3\u2032UTR of the mouse catalase (Cas-1). DNA Cell Biol 20: 339\u2013348.","journal-title":"DNA Cell Biol"},{"key":"BF1300232_CR45","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0306-4522(97)00046-8","volume":"79","author":"P Svenningsson","year":"1997","unstructured":"Svenningsson P, Nomikos GG, Ongini E, Fredholm BB (1997). Antagonism of adenosine A2A receptors underlies the behavioral activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience 79: 753\u2013764.","journal-title":"Neuroscience"},{"key":"BF1300232_CR46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF00427598","volume":"67","author":"E Svensson","year":"1980","unstructured":"Svensson E, Persson LO, Sjoberg L (1980). Mood effects of diazepam and caffeine. Psychopharmacology 67: 73\u201380.","journal-title":"Psychopharmacology"},{"key":"BF1300232_CR47","first-page":"426","volume":"20","author":"TW Uhde","year":"1984","unstructured":"Uhde TW, Boulanger JP, Vittone B, Jimerson DC, Post PM (1984). Caffeine: relationship to human anxiety plasma MHPG and cortisol. Psychopharmacol Bull 20: 426\u2013430.","journal-title":"Psychopharmacol Bull"},{"key":"BF1300232_CR48","doi-asserted-by":"publisher","DOI":"10.1037\/11167-000","volume-title":"The Measure and Appraisal of Adult Intelligence","author":"D Wechsler","year":"1958","unstructured":"Wechsler D (1958). The Measure and Appraisal of Adult Intelligence. Williams and Wilkins: Baltimore."},{"key":"BF1300232_CR49","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1126\/science.7433978","volume":"209","author":"BC White","year":"1980","unstructured":"White BC, Lincoln CA, Pearce NW, Reeb R, Vaida C (1980). Anxiety and muscle tension as consequences of caffeine withdrawal. Science 209: 1547\u20131548.","journal-title":"Science"},{"key":"BF1300232_CR50","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s007020170033","volume":"108","author":"K Yamada","year":"2001","unstructured":"Yamada K, Hattori E, Shimizu M, Sugaya A, Shibuya H, Yoshikawa T (2001). Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder. J Neural Transm 108: 837\u2013848.","journal-title":"J Neural Transm"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300232","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T23:50:45Z","timestamp":1704844245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,14]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["BF1300232"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300232","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,14]]}}}